Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use
LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a
Read more